{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:51:53Z","timestamp":1790041913381,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13052-019-0624-z","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T11:44:30Z","timestamp":1552563870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache"],"prefix":"10.1186","volume":"45","author":[{"given":"Filomena","family":"Moscano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Guiducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Maltoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Striano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giuseppina","family":"Ledda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zoroddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Raucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9042-8120","authenticated-orcid":false,"given":"Pasquale","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"issue":"8","key":"624_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11916-017-0638-4","volume":"21","author":"J Kacperski","year":"2017","unstructured":"Kacperski J, Bazarsky A. New developments in the prophylactic drug treatment of pediatric migraine: what is new in 2017 and where does it leave us? Curr Pain Headache Rep. 2017;21(8):38. \n                    https:\/\/doi.org\/10.1007\/s11916-017-0638-4\n                    \n                  .","journal-title":"Curr Pain Headache Rep"},{"key":"624_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1468-2982.2004.00652.x","volume":"24","author":"SW Powers","year":"2004","unstructured":"Powers SW, Patton SR, Hommel KA, Hershey AD. Quality of life in paediatric migraine: Characterization of age-related effects using Peds QL 4.0. Cephalalgia. 2004;24:120\u20137.","journal-title":"Cephalalgia"},{"issue":"1","key":"624_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1\u2013211.","journal-title":"Cephalalgia"},{"key":"624_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10194-010-0256-6","volume":"12","author":"C Termine","year":"2011","unstructured":"Termine C, Ozge A, Antonacci F, Natriashvili S, Guidetti V, Wober-Bingol C. Overview of diagnosis and management of pediatric headache. Part II: therapeutic management. J Headache Pain. 2011;12:25\u201334.","journal-title":"J Headache Pain"},{"key":"624_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1046\/j.1468-2982.1998.1807449.x","volume":"18","author":"V Guidetti","year":"1998","unstructured":"Guidetti V, Galli F. Evolution of headache in childhood and adolescents: an 8-year follow up. Cephalalgia. 1998;18:449\u201354.","journal-title":"Cephalalgia"},{"issue":"9","key":"624_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41582-018-0042-7","volume":"14","author":"SL Orr","year":"2018","unstructured":"Orr SL, Kabbouche MA, O'Brien HL, et al. Paediatric migraine: evidence-based management and future directions. Nat Rev Neurol. 2018;14(9):515\u201327.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"624_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1001\/jamapediatrics.2013.508","volume":"167","author":"K El-Chammas","year":"2013","unstructured":"El-Chammas K, Keyes J, Thompson N, Vijayakumar J, Becher D, Jackson JL. A comparative effectiveness meta-analysis of drugs for the prophylaxis of pediatric migraine headache. JAMA Pediatr. 2013;167(3):250\u20138. \n                    https:\/\/doi.org\/10.1001\/jamapediatrics.2013.508\n                    \n                  .","journal-title":"JAMA Pediatr"},{"issue":"1","key":"624_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/1756285615616586","volume":"9","author":"J Kacperski","year":"2016","unstructured":"Kacperski J, Kabbouche MA, O\u2019Brien HL, Weberding JL. The optimal management of headaches in children and adolescents. Ther Adv Neurol Disord. 2016;9(1):53\u201368. \n                    https:\/\/doi.org\/10.1177\/1756285615616586\n                    \n                  .","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"624_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa1610384","volume":"376","author":"SW Powers","year":"2017","unstructured":"Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, et al. Trial of amitriptyline, topiramate, and place- Bo for pediatric migraine. N Engl J Med. 2017;376(2):115\u201324.","journal-title":"N Engl J Med"},{"key":"624_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1468-2982.2008.01752.x","volume":"29","author":"S Evers","year":"2009","unstructured":"Evers S, Marziniak M, Frese A, Gralow I. Placebo efficacy in childhood and adolescence migraine: an analysis of double blind and placebo-controlled studies. Cephalalgia. 2009;29:436\u201344.","journal-title":"Cephalalgia."},{"issue":"Suppl 1","key":"624_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10072-017-2896-7","volume":"38","author":"R Sangermani","year":"2017","unstructured":"Sangermani R, Boncimino A. The use of nutraceutics in children's and adolescent's headache. Neurol Sci. 2017;38(Suppl 1):121\u20134.","journal-title":"Neurol Sci"},{"key":"624_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629\u2013808.","journal-title":"Cephalalgia"},{"issue":"3","key":"624_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/1740774512438980","volume":"9","author":"ST Grinnon","year":"2012","unstructured":"Grinnon ST, Miller K, Marler JR, Lu Y, Stout A, Odenkirchen J, Kunitz S. National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods. Clin Trials. 2012;9(3):322\u20139 Epub 2012 Feb27.","journal-title":"Clin Trials"},{"issue":"17","key":"624_CR14","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0b013e3182535d0c","volume":"78","author":"S Holland","year":"2012","unstructured":"Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the quality standards Subcommittee of the American Academy of neurology and the American headache society. Neurology. 2012;78(17):1346\u201353.","journal-title":"Neurology."},{"issue":"1","key":"624_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.11138\/FNeur\/2016.31.1.053","volume":"31","author":"R Greco","year":"2016","unstructured":"Greco R, Siani F, Demartini C, et al. Andrographis paniculata shows anti-nociceptive effects in an animal model of sensory hypersensitivity associated with migraine. Functional Neurology. 2016;31(1):53\u201360. \n                    https:\/\/doi.org\/10.11138\/FNeur\/2016.31.1.053\n                    \n                  .","journal-title":"Functional Neurology"},{"key":"624_CR16","unstructured":"Societ\u00e0 Italiana per lo Studio delle Cefalee. Linee Guida per la diagnosi e la terapia delle cefalee primarie 2011."},{"key":"624_CR17","doi-asserted-by":"publisher","unstructured":"Wider B, Pittler MH, Ernst E. Feverfew for preventing migraine. Cochrane Database Syst Rev. 2015, Issue 4. Art. No.: CD002286. DOI: \n                    https:\/\/doi.org\/10.1002\/14651858.CD002286.pub3\n                    \n                  .","DOI":"10.1002\/14651858.CD002286.pub3"},{"key":"624_CR18","doi-asserted-by":"crossref","unstructured":"Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM. The anti-inflammatory natural product parthenolide from the medicinal herb feverfew directly binds to and inhibits IkappaB kinase. Chem Biol 2001;8(8):759\u2013766. PubMed PMID: \n                    11514225","DOI":"10.1016\/S1074-5521(01)00049-7"},{"key":"624_CR19","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1468-2982.2005.00915.x","volume":"25","author":"C Tassorelli","year":"2005","unstructured":"Tassorelli C, Greco R, Morazzoni P, Riva A, Sandrini G, Nappi G. Parthenolide is the component of Tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine. Cephalalgia: An International Journal of Headache. 2005;25:612\u201321.","journal-title":"Cephalalgia: An International Journal of Headache"},{"issue":"12","key":"624_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pain.2013.08.002","volume":"154","author":"S Materazzi","year":"2013","unstructured":"Materazzi S, Benemei S, Fusi C, et al. Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting TRPA1 channel. Pain. 2013;154(12):10.","journal-title":"Pain."},{"issue":"4","key":"624_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11940-016-0398-1","volume":"18","author":"O Daniel","year":"2016","unstructured":"Daniel O, Mauskop A. Nutraceuticals in acute and prophylactic treatment of migraine. Curr Treat Options Neurol. 2016;18(4):14.","journal-title":"Curr Treat Options Neurol"},{"issue":"3","key":"624_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1526-4610.2011.01847.x","volume":"51","author":"FR Taylor","year":"2011","unstructured":"Taylor FR. Nutraceuticals and headache: the biological basis. Headache. 2011;51(3):484\u2013501.","journal-title":"Headache."},{"key":"624_CR23","doi-asserted-by":"publisher","unstructured":"Cevoli S, Favoni V, Cortelli P. Energy metabolism impairment in migraine. Curr Med Chem. 2018. \n                    https:\/\/doi.org\/10.2174\/0929867325666180622154411\n                    \n                   [Epub ahead of print].","DOI":"10.2174\/0929867325666180622154411"},{"issue":"Suppl 2","key":"624_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1526-4610.2012.02233.x","volume":"52","author":"HG Markley","year":"2012","unstructured":"Markley HG. CoEnzyme Q10 and riboflavin: the mitochondrial connection. Headache. 2012;52(Suppl 2):81\u20137.","journal-title":"Headache."},{"issue":"4","key":"624_CR25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1212\/01.WNL.0000151975.03598.ED","volume":"64","author":"PS S\u00e1ndor","year":"2005","unstructured":"S\u00e1ndor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64(4):713\u20135.","journal-title":"Neurology."},{"issue":"5","key":"624_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11916-018-0692-6","volume":"22","author":"SL Orr","year":"2018","unstructured":"Orr SL. The evidence for the role of nutraceuticals in the Management of Pediatric Migraine: a review. Curr Pain Headache Rep. 2018;22(5):37.","journal-title":"Curr Pain Headache Rep"},{"issue":"1\u20132","key":"624_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cccn.2004.02.016","volume":"344","author":"MV Miles","year":"2004","unstructured":"Miles MV, Morrison JA, Horn PS, Tang PH, Pesce AJ. Coenzyme Q10 changes are associated with metabolic syndrome. Clin Chim Acta. 2004;344(1\u20132):173\u20139.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"624_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1586\/14737175.9.3.369","volume":"9","author":"C Sun-Edelstein","year":"2009","unstructured":"Sun-Edelstein C, Mauskop A. Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother. 2009;9(3):369\u201379.","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"624_CR29","first-page":"66","volume":"16","author":"S Akbar","year":"2011","unstructured":"Akbar S. Andrographis paniculata: a review of pharmacological activities and clinical effects. Altern Med Rev. 2011;16(1):66\u201377.","journal-title":"Altern Med Rev"},{"issue":"4","key":"624_CR30","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.3928\/19382359-20170321-02","volume":"46","author":"HK Blume","year":"2017","unstructured":"Blume HK. Childhood headache: a brief review. Pediatr Ann. 2017;46(4):e155\u201365.","journal-title":"Pediatr Ann"},{"issue":"5","key":"624_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/head.12105","volume":"53","author":"AD Hershey","year":"2013","unstructured":"Hershey AD, Powers SW, Coffey CS, et al. Childhood and adolescent migraine prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, Topiramate and placebo in the prevention of childhood and adolescent migraine. Headache. 2013;53(5):799\u2013816. \n                    https:\/\/doi.org\/10.1111\/head.12105\n                    \n                  .","journal-title":"Headache."}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-019-0624-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13052-019-0624-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-019-0624-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T20:24:21Z","timestamp":1583871861000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-019-0624-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1186\/s13052-019-0624-z","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"assertion":[{"value":"8 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the Authors gave the consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. No honorarium, grant, or other form of payment was given to anyone to produce the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"36"}}